 |
 |
|
Drug Discovery & Development of Innovative Therapeutics Japan
如何及早取得POC
2008年5月７日（三）～ 9日（五）
京王广场饭店 （KEIO PLAZA HOTEL）（东京）
|
|
赞助商
2008年3月26日UPDATE | Silver Sponsors |  | Asterand, www.asterand.com is the leading supplier of high quality human tissue as well as tissue-based Phase Zero drug discovery services - Gene Expression Profiling, Protein Expression Profiling, Tissue Pharmacology, and ADMET assays. These services utilize human tissues in experiments previously limited to animal models or in vitro cell cultures. |  | Aurigene is a world-class small-molecule Discovery company with integrated infrastructure and experience of successfully developing multiple programs to the Lead Optimization phase. Aurigene partners early-stage Drug Discovery programs with Pharmaceutical companies, for high-quality innovation at Indian costs. Aurigene also develops First- and best-in-class compounds for licensing and co-development. In addition, Aurigene provides Chemistry, Assay and Structural Biology services. Aurigene's Discovery partners include MerckSerono, Forest, Rheoscience, Debiopharm, Orion Pharma, Novo Nordisk etc. |  | PRTM management consultants create competitive advantage for clients by changing the way companies operate. PRTM works with senior executives to create the operational strategies that deliver breakthrough results. The firm leads in supply chain, product development, and customer value management. PRTM has 16 offices worldwide and serves major industry and public sectors. For more information, visit www.prtm.com. |  | |  | SRI International is an independent, non-profit research institute. Our Biosciences Division is a fully integrated "idea to IND(R)" drug discovery and development organization. SRI Biosciences conducts basic research on disease mechanisms like an academic institution, performs drug discovery like a biotechnology company, and offers full-service preclinical drug development like a contract research organization. This unique business model interfaces government-funded target/pathway research and small molecule drug discovery with commercial partnerships to develop clinical-ready drug candidates at greatly reduced risk. |  | TCG Lifesciences is a leading integrated research services and informatics organization operating out of India. It's mission is to serve the global life sciences industry through cooperation and strategic partnerships for developing superior drugs and biologics. It is providing services to the global pharmaceutical and biotechnology companies in the areas of discovery research, translational research & clinical development and enterprise informatics services. |  | TriStar Technology Group has the world's largest commercially available repository of over 60,000 micro arrayed human tissues. Annotated data includes progression, prognosis, treatment and response. Large-scale analysis of biomarker expression/amplification in Cancer and Neurodegenerative disease tissues is offered on a fee-for service basis. TriStar is based in Rockville, Maryland with research labs & repositories in Hamburg, Germany and Catania, Italy. |  | Since our foundation, under a consistent management policy, Wako Pure Chemical Industries, Ltd. has been provided unique technological capabilities - our core competence - to focus on three key operational areas, namely, Laboratory Chemicals, Specialty Chemicals, and Diagnostic Reagents, and to meet the diverse requirements of researchers, medical professionals and industry. | | | Bronze Sponsors |  | GNI is a global pharmaceutical company dedicated to the discovery, development, and commercialization of new drugs for the treatment of diseases prevalent in Asia. A pioneer in the field of systems pharmacology, GNI applies gene network analysis and other cutting-edge biotech tools to develop drugs that alleviate suffering from pulmonary disease, liver cirrhosis, cancer, inflammation, and other medical conditions. GNI holds licenses to a series of patents for pharmaceuticals that target these areas. For more information, visit: www.gene-networks.com. |  | KaloBios Pharmaceuticals is a therapeutic antibody company using its proprietary antibody engineering technology, Humaneering(TM), for the development of a pipeline of antibody therapeutics. Its two most advanced drug candidates are KB001 and KB002. KB001 is designed to treat life-threatening Pseudomonas aeruginosa lung infections, a common problem of cystic fibrosis and mechanically ventilated patients. KB002 is designed for the treatment of rheumatoid arthritis, asthma, and other autoimmune diseases. For more information, visit www.kalobios.com. | | | Associate Sponsor |  | TFS Trial Form Support International is a full-service clinical CRO with headquarters in Lund, Sweden. Since 1996, TFS has provided the life science industry with a wide range of clinical contract services. TFS is currently conducting pan-European clinical trials in 20 countries. Over 400 highly competent employees are working from 14 countries across Europe and offices in India and Japan. | | | Technology Workshop Sponsors |  | InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology improving the potency of existing antibody products while opening new markets and disease applications. DXL(TM) antibodies utilize unique, novel and patented methods and technologies of InNexus. Please visit www.ixsbio.com. |  | Invitrogen develops life science technologies for molecular and cell biology, bioproduction and clinical applications. We accelerate biological understanding through technologies and services that include leading industry names such as GIBCO, Molecular Probes, Dynal, Quantum Dot, Zymed, and BioSource. Our portfolio spans the breadth of drug applications and emerging areas. | | | Notepad Sponsor | | |
|
